Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-10-15

Clinical Trial Update: Gabapentin For the Control of Hot Flashes in Women With Breast Cancer [NA]

View source ↗

Summary

A ClinicalTrials.gov update indicates that a study evaluating gabapentin for reducing hot flashes in women with breast cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

Sponsor: Gary Morrow | Conditions: Anxiety Disorder, Breast Cancer | NA | Status: COMPLETED